SIGA Technologies, Inc. (NASDAQ:SIGA - Get Free Report)'s stock price reached a new 52-week high on Monday . The stock traded as high as $9.00 and last traded at $8.90, with a volume of 386946 shares changing hands. The stock had previously closed at $8.56.
SIGA Technologies Price Performance
The firm has a 50 day simple moving average of $5.82 and a two-hundred day simple moving average of $5.49. The stock has a market cap of $624.88 million, a price-to-earnings ratio of 9.36 and a beta of 0.94.
SIGA Technologies Increases Dividend
The business also recently announced a dividend, which will be paid on Thursday, April 11th. Shareholders of record on Tuesday, March 26th will be paid a $0.60 dividend. This is a positive change from SIGA Technologies's previous dividend of $0.45. The ex-dividend date is Monday, March 25th.
Institutional Investors Weigh In On SIGA Technologies
Large investors have recently modified their holdings of the business. Point72 Middle East FZE bought a new stake in shares of SIGA Technologies in the fourth quarter worth about $27,000. Tower Research Capital LLC TRC increased its holdings in shares of SIGA Technologies by 200.6% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,955 shares of the company's stock worth $45,000 after acquiring an additional 5,309 shares in the last quarter. China Universal Asset Management Co. Ltd. increased its holdings in shares of SIGA Technologies by 351.7% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 8,225 shares of the company's stock worth $46,000 after acquiring an additional 6,404 shares in the last quarter. UBS Group AG increased its holdings in shares of SIGA Technologies by 30.3% in the second quarter. UBS Group AG now owns 4,596 shares of the company's stock worth $53,000 after acquiring an additional 1,070 shares in the last quarter. Finally, Evergreen Capital Management LLC bought a new stake in shares of SIGA Technologies in the third quarter worth about $57,000. 55.40% of the stock is currently owned by institutional investors.
SIGA Technologies Company Profile
(
Get Free Report)
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
See Also
Before you consider SIGA Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SIGA Technologies wasn't on the list.
While SIGA Technologies currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
